Literature DB >> 7680815

Effects of antihistamine medications on exercise performance. Implications for sportspeople.

L C Montgomery1, P A Deuster.   

Abstract

The athlete who suffers from atopic diseases such as seasonal allergic rhinitis has an arsenal of antihistamines from which to choose for relief of symptoms. The decision to select a particular medication involves consideration of its efficacy and its side effects. Many of the standard antihistamines have sedative side effects which render them undesirable for use by athletes during competition. For example, a survey of studies suggests that some of these medications may compromise the performance of psychomotor skills important to the athlete (e.g. reaction time and visual discrimination). The newer, nonsedating antihistamines are equal to the standard agents in efficacy and comparable with placebo in central nervous system effects. Thus, psychomotor performance is not adversely affected by the newer antihistamines. Despite their widespread use, the effects of treatment with antihistamines on exercise performance (e.g. metabolic responses and time to exhaustion) have scarcely been addressed. The few studies available indicate that single oral administrations of antihistamines neither compromise nor enhance exercise performance or tolerance in asymptomatic individuals. Yet the research conducted has not examined the effects of antihistamine ingestion on exercise performance in symptomatic individuals. Whether treatment with an antihistamine would improve exercise performance relative to nontreatment in symptomatic, atopic athletes remains to be determined. Whereas there is a dearth of information on the effects of antihistamine medications on exercise performance, there is growing evidence that pretreatment with antihistamines may prevent or attenuate some exercise-induced histamine-mediated disorders such as urticaria, pruritus, anaphylaxis and gastrointestinal bleeding. A survey of studies suggests that prophylactic treatment with antihistamines may increase tolerance to exercise in individuals susceptible to these disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680815     DOI: 10.2165/00007256-199315030-00004

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  103 in total

1.  Ingestion of an antihistamine does not affect exercise performance.

Authors:  L C Montgomery; P A Deuster
Journal:  Med Sci Sports Exerc       Date:  1992-03       Impact factor: 5.411

2.  Acute antihistamine ingestion does not affect muscle strength and endurance.

Authors:  L C Montgomery; P A Deuster
Journal:  Med Sci Sports Exerc       Date:  1991-09       Impact factor: 5.411

3.  Reliability of an isokinetic test of muscle strength and endurance.

Authors:  L C Montgomery; L W Douglass; P A Deuster
Journal:  J Orthop Sports Phys Ther       Date:  1989       Impact factor: 4.751

4.  History of exercise-induced asthma.

Authors:  R M Sly
Journal:  Med Sci Sports Exerc       Date:  1986-06       Impact factor: 5.411

5.  A multicentre controlled trial of terfenadine, dexchlorpheniramine, and placebo in allergic rhinitis.

Authors:  G Melillo; G D'Amato; C Zanussi; C Ortolani; E Pastorello; M Loy; A Di Tucci; F Locci; G S Del Giacco; L Lenzini; P Sestini; P Rottoli
Journal:  Arzneimittelforschung       Date:  1982

6.  Multicenter, crossover study of the efficacy and tolerability of terfenadine, 120 mg, versus cetirizine, 10 mg, in perennial allergic rhinitis.

Authors:  R Renton; C Fidler; R Rosenberg
Journal:  Ann Allergy       Date:  1991-10

Review 7.  Exercise-induced asthma, anaphylaxis, and urticaria.

Authors:  R H Kobayashi; M B Mellion
Journal:  Prim Care       Date:  1991-12       Impact factor: 2.907

8.  Exercise and the asthmatic.

Authors:  A Bundgaard
Journal:  Sports Med       Date:  1985 Jul-Aug       Impact factor: 11.136

9.  Antihistamine- and decongestant-induced performance decrements.

Authors:  E O Meltzer
Journal:  J Occup Med       Date:  1990-04

10.  Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways.

Authors:  P Rafferty; S T Holgate
Journal:  Am Rev Respir Dis       Date:  1987-01
View more
  5 in total

Review 1.  Use of prescription drugs in athletes.

Authors:  Antti Alaranta; Hannu Alaranta; Ilkka Helenius
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 2.  The Intriguing Role of Histamine in Exercise Responses.

Authors:  Meredith J Luttrell; John R Halliwill
Journal:  Exerc Sport Sci Rev       Date:  2017-01       Impact factor: 6.230

3.  Histamine-Receptor Antagonists Slow 10-km Cycling Performance in Competitive Cyclists.

Authors:  Matthew R Ely; Dylan C Sieck; Joshua E Mangum; Emily A Larson; Leandro C Brito; Christopher T Minson; John R Halliwill
Journal:  Med Sci Sports Exerc       Date:  2019-07       Impact factor: 5.411

Review 4.  Allergic rhinoconjunctivitis in elite athletes: optimal management for quality of life and performance.

Authors:  Constance H Katelaris; Fiona M Carrozzi; Therese V Burke
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 5.  Seasonal allergy and seasonal decrements in athletic performance.

Authors:  Hirsh D Komarow; Teodor T Postolache
Journal:  Clin Sports Med       Date:  2005-04       Impact factor: 2.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.